High-performance liquid chromatographic determination of busulfan in plasma

[1]  M. Chandy,et al.  High-performance liquid chromatographic method for quantification of busulfan in plasma after derivatization by tetrafluorothiophenol. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[2]  J. Kralovánszky,et al.  High-Performance liquid chromatographic determination of dibromomannitol in plasma , 1998 .

[3]  B. Andersson,et al.  Stability-indicating high-performance liquid chromatographic assay of busulfan in aqueous and plasma samples. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[4]  J. Spinelli,et al.  Validation of a high-performance liquid chromatographic assay method for pharmacokinetic evaluation of busulfan. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[5]  H. Deeg,et al.  Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. , 1997, Blood.

[6]  N. Rifai,et al.  Measurement of plasma busulfan concentration by high-performance liquid chromatography with ultraviolet detection. , 1997, Therapeutic drug monitoring.

[7]  R. Storb,et al.  Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels. , 1996, Bone marrow transplantation.

[8]  J. E. Quintanilla-López,et al.  Measuring specific retention volumes in capillary gas chromatography with improved accuracy and precision , 1996 .

[9]  R. Storb,et al.  Transplantation of allogeneic peripheral blood stem cells , 1995, Stem cells.

[10]  F. Appelbaum,et al.  Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. , 1995, Bone marrow transplantation.

[11]  G. Vassal,et al.  Pharmacologically-guided dose adjustment of busulfan in high-dose chemotherapy regimens: rationale and pitfalls (review). , 1994, Anticancer research.

[12]  W. Chao,et al.  High-performance liquid chromatographic determination of busulfan in human serum with on-line derivatization, column switching and ultraviolet absorbance detection. , 1994, Journal of chromatography. B, Biomedical applications.

[13]  D. Schuler,et al.  Pharmacokinetic studies on Elobromol in children with brain tumors , 1994, Anti-cancer drugs.

[14]  L. Grochow.  Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens. , 1993, Seminars in oncology.

[15]  A. Fischer,et al.  Busulfan disposition below the age of three: alteration in children with lysosomal storage disease. , 1993, Blood.

[16]  E. Shpall,et al.  Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine. , 1993, Journal of the National Cancer Institute.

[17]  L. Grochow,et al.  Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation. , 1992, Blood.

[18]  A. Rosowsky,et al.  Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  G. Vassal,et al.  Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. , 1990, Cancer research.

[20]  G. Ehninger,et al.  Quantitation of busulfan in plasma by high-performance liquid chromatography using postcolumn photolysis. , 1990, Journal of chromatography.

[21]  L. Grochow,et al.  Determination of busulfan in human plasma by gas chromatography with electron-capture detection. , 1988, Journal of chromatography.

[22]  G. Vassal,et al.  Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standard. , 1988, Journal of chromatography.

[23]  L. Grochow,et al.  VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION , 1987, Transplantation.

[24]  T. Shea,et al.  Measurement of busulfan in plasma by high-performance liquid chromatography. , 1987, Journal of chromatography.

[25]  C. Patte,et al.  High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  P. Shaw,et al.  Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children. , 1986, Bone marrow transplantation.

[27]  S. Kelley,et al.  Pharmacokinetics of dibromodulcitol in humans: a phase I study. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  G. Lucarelli,et al.  Marrow Transplantation for Thalassemia after Treatment with Busulfan and Cyclophosphamide a , 1985, Annals of the New York Academy of Sciences.

[29]  R. Brookmeyer,et al.  Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. , 1983, The New England journal of medicine.

[30]  H. Ehrsson,et al.  Gas chromatographic determination of busulfan in plasma with electron-capture detection. , 1983, Journal of chromatography.

[31]  T. Higuchi,et al.  High-performance liquid chromatographic analysis of dianhydrogalactitol in plasma by derivatization with sodium diethyldithiocarbamate. , 1977, Journal of chromatography.